期刊文献+

社区获得性肺炎研究进展 被引量:4

Advance on community-acquired pneumonia
原文传递
导出
摘要 社区获得性肺炎(community acquired pneumonia,CAP)的病原谱国内外有所差异,国外调查资料以肺炎链球菌为其首位病原体,非典型病原体是重要病原体。国内CAP病原体则以非典型病原体为主,肺炎链球菌所占比例相对较低。肺炎链球菌的耐药率因地而异。血清非典型病原体抗体检测和尿中各种肺炎病原体抗原检测是CAP病原体诊断的重要措施。聚合酶链反应诊断CAP病原体具有广阔的应用前景。抗菌药物早期静脉-口服切换和缩短抗菌药物疗程是CAP治疗方面的进展之一。 Community-acquired pneumonia(CAP) is one of major issues to the health of human around world. The etiology of CAP varies among different areas. The single most prevalent organism of CAP is Streptococcus pneumoniae in most countries, while two multi-center studies in China showed that it was Mycoplasma pneumoniae or Haemophilus influenzae. Atypical pathogens have contributed significantly to the etiology of CAP. The antimicrobial susceptibility of Streptococcus pneumoniae varies according to the areas. The serum antibody and urinary antigen tests are common available for establishment of causative pathogens of CAP. Polymerase chain reaction is the potential diagnostic technique for some pathogens. Both effectiveness of early switch from intravenous to oral antibiotics and short duration of antibiotics therapy in CAP come into focus.
作者 秦志强
出处 《国际呼吸杂志》 2008年第4期219-222,共4页 International Journal of Respiration
关键词 社区获得性肺炎 病原学 诊断 治疗 Community-acquired pneumonia Etiology Diagnosis Treatment
  • 相关文献

参考文献28

  • 1Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis, 2007,44 (Suppl 2) : S27-72.
  • 2Viegi G,Pistelli R,Cazzola M, et al. Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy. Respir Med,2006,100:46-55.
  • 3Almirall J, Boloabar I, Vidal J, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J, 2000,15:757-763.
  • 4Gutierrez F, Masia M, Rodriguez JC, et al. Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century:a prospective study on the Mediterranean coast of Spain. Clin Microbiol Infect,2005,11:788-800.
  • 5Ishida T, Hashimoto T, Arita M, et al. Etiology of communityacquired pneumonia in hospitalized patients:a 3-year prospective study in Japan. Chest, 1998,114:1588-1593.
  • 6Saito A,Kohno S, Matsushima T, et al. Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan. J Infect Chemother, 2006,12:63-69.
  • 7Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J,2002, 20(Suppl 36) :20s-27s.
  • 8Howard LS,Sillis M, Pasteur MC, et al. Microbiological profile of community-acquired pneumonia in adults over the last 20 years. J Infect,2005,50:107-113.
  • 9刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:788
  • 10Huang HH, Zhang YY, Xiu QY, et al. Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients. Eur J Clin Microbiol Infect Dis,2006,25:369-374.

二级参考文献36

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:788
  • 3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 4Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
  • 5Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
  • 6Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
  • 7Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
  • 8Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 9de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 10Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.

共引文献3571

同被引文献18

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部